Association between obesity, hypertriglyceridemia and low hepatitis B viral load

International Journal of Obesity

Volumn 37, Issue 3, 2013, Pages 410-415

  Chiang, C H ^a   Yang, H I ^b,c   Jen, C L ^d   Lu, S N ^e   Wang, L Y ^f   You, S L ^d   Su, J ^g,h   Iloeje, U H ^g   Chen, C J ^d,h  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f MACKAY MEDICAL COLLEGE   (Taiwan)

^g BRISTOL MYERS SQUIBB   (United States)

^h NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

hepatitis B e antigen; hepatitis B viral load; metabolic factor; triglycerides

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; INFECTION RISK; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS LOAD;

ALANINE TRANSAMINASE; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; OBESITY, MORBID; ODDS RATIO; PREVALENCE; RISK FACTORS; TAIWAN; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 84875227543     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.63     Document Type: Article

References (40)

1. Chen CJ, Yang HI. Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol 2011; 26: 628-638
2. Chen CJ, Yang HI, Iloeje UH. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009; 49: S72-S84
3. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73
4. Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 2007; 5: 921-931
5. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-686
6. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582-592
7. Shlomai A, Shaul Y. The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Med Hypotheses 2008; 71: 53-57
8. Huang KC. Obesity and its related diseases in Taiwan. Obes Rev 2008; 9(Suppl 1): 32-34
9. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-121
10. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005; 54: 533-539
11. Inoue M, Kurahashi N, Iwasaki M, Tanaka Y, Mizokami M, Noda M et al. Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II). Cancer Causes Control 2009; 20: 741-750
12. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006; 43: 1295-1302
13. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009; 58: 111-117
14. Yu MW, Shih WL, Lin CL, Liu CJ, Jian JW, Tsai KS et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 2008; 26: 5576-5582
15. Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2008; 27: 80-89
16. Chiang CH, Lai JS, Sheu JC, Yen LL, Liu CJ, Huang KC. The risky body mass index ranges for significant hepatitis B viral load: A campus-based study. Obes Res Clin Pract 2012; 6: e31-e38
17. WHO. Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163
18. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-174
19. Huang Y, Lok AS. Viral factors and outcomes of chronic HBV infection. Am J Gastroenterol 2011; 106: 93-95
20. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 2009; 50: 1392-1402
21. Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN et al. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol 2011; 29: 3643-3650
22. Chen YC, Chu CM, Liaw YF. Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology 2010; 51: 435-444
23. Yeap BB, Chubb SA, Hyde Z, Jamrozik K, Hankey GJ, Flicker L et al. Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. Eur J Endocrinol 2009; 161: 591-598
24. Traish AM, Feeley RJ, Guay A. Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction. FEBS J 2009; 276: 5755-5767
25. Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB. Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab 2008; 93: 3403-3410
26. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295: 1288-1299
27. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009; 361: 1152-1163
28. Yang WJ, Chang CJ, Yeh SH, Lin WH, Wang SH, Tsai TF et al. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways. Hepatology 2009; 49: 1515-1524
29. Shlomai A, Shaul Y. The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription. Biochem Biophys Res Commun 2009; 381: 544-548
30. Jan CF, Chen CJ, Chiu YH, Chen LS, Wu HM, Huang CC et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes 2006; 30: 794-799
31. Wong VW, Wong GL, Chu WC, Chim AM, Ong A, Yeung DK et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol 2012; 56: 533-540
32. Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta 2007; 380: 238-240
33. Kang SK, Chung TW, Lee JY, Lee YC, Morton RE, Kim CH. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. J Biol Chem 2004; 279: 28106-28112
34. Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 2007; 11: 75-104i.x.
35. Tsochatzis E, Papatheodoridis GV, Manesis EK, Chrysanthos N, Kafiri G, Archimandritis AJ. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C. Dig Liver Dis 2007; 39: 936-942
36. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 2009; 49: 306-317
37. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55: 560-578
38. Lee IC, Huang YH, Chan CC, Huo TI, Chu CJ, Lai CR et al. Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B. Clin Nutr 2011; 30: 647-652
39. Kumar M, Choudhury A, Manglik N, Hissar S, Rastogi A, Sakhuja P et al. Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol 2009; 104: 76-82
40. Zheng RD, Xu CR, Jiang L, Dou AX, Zhou K, Lu LG. Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis. Int J Med Sci 2010; 7: 272-277.